Literature DB >> 24382204

Expression of matriptase correlates with tumour progression and clinical prognosis in oral squamous cell carcinoma.

Ming-Fang Cheng1, Mao-Suan Huang, Chun-Shu Lin, Li-Han Lin, Herng-Sheng Lee, Jhih-Cheng Jiang, Kan-Tai Hsia.   

Abstract

AIMS: To investigate the relationship of matriptase expression in oral squamous cell carcinoma (OSCC) to clinicopathological characteristics, patient survival and cell-invasive properties. METHODS AND
RESULTS: Matriptase expression in OSCC was evaluated by immunohistochemical staining, and its relationship to clinicopathological features and outcomes was assessed statistically. The shRNA-mediated stable knockdown of matriptase in OSCC cells was used to analyse cell proliferation, migration and invasion in vitro. Matriptase immunostaining score was correlated with histopathological grade, clinical stage, positive lymph node and distant metastasis, and higher matriptase immunostaining score was associated significantly with poor prognosis. Elevated matriptase expression in oral cancer cell lines was a significant promoter of oral cancer cell migration and invasion.
CONCLUSIONS: Matriptase expression correlates with tumour progression and invasive capability in OSCC and may be an adverse prognostic marker for this cancer.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  matriptase; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24382204     DOI: 10.1111/his.12361

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  Proteases and HPV-Induced Carcinogenesis.

Authors:  Gabriel Viliod Vieira; Fernanda Somera Dos Santos; Ana Paula Lepique; Carol Kobori da Fonseca; Lara Maria Alencar Ramos Innocentini; Paulo Henrique Braz-Silva; Silvana Maria Quintana; Katiuchia Uzzun Sales
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

Review 2.  Cell surface-anchored serine proteases in cancer progression and metastasis.

Authors:  Carly E Martin; Karin List
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

Review 3.  Type II transmembrane serine proteases as potential targets for cancer therapy.

Authors:  Andrew S Murray; Fausto A Varela; Karin List
Journal:  Biol Chem       Date:  2016-09-01       Impact factor: 3.915

Review 4.  Mechanisms of hepatocyte growth factor activation in cancer tissues.

Authors:  Makiko Kawaguchi; Hiroaki Kataoka
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

5.  Protease signaling regulates apical cell extrusion, cell contacts, and proliferation in epithelia.

Authors:  Antonino Schepis; Adrian Barker; Yoga Srinivasan; Eaman Balouch; Yaowu Zheng; Ian Lam; Hilary Clay; Chung-Der Hsiao; Shaun R Coughlin
Journal:  J Cell Biol       Date:  2018-01-04       Impact factor: 10.539

6.  Co-Expression of a Chimeric Protease Inhibitor Secreted by a Tumor-Targeted Salmonella Protects Therapeutic Proteins from Proteolytic Degradation.

Authors:  David Quintero; Jamie Carrafa; Lena Vincent; Hee Jong Lee; James Wohlschlegel; David Bermudes
Journal:  J Microbiol Biotechnol       Date:  2018-12-28       Impact factor: 3.277

7.  Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors.

Authors:  K U Sales; S Friis; L Abusleme; N M Moutsopoulos; T H Bugge
Journal:  Oncogene       Date:  2014-12-08       Impact factor: 9.867

8.  Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells.

Authors:  Koji Yamamoto; Makiko Kawaguchi; Takeshi Shimomura; Aya Izumi; Kazuomi Konari; Arata Honda; Chen-Yong Lin; Michael D Johnson; Yoshihiro Yamashita; Tsuyoshi Fukushima; Hiroaki Kataoka
Journal:  Oncotarget       Date:  2018-02-08

Review 9.  Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers.

Authors:  Shoichiro Mukai; Koji Yamasaki; Masato Fujii; Takahiro Nagai; Naoki Terada; Hiroaki Kataoka; Toshiyuki Kamoto
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.